Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00191802
Status:
COMPLETED
Last Update Posted:
2007-01-26
First Post:
2005-09-12
Brief Title:
Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Study Overview
Official Title:
Compliance With and Acceptance of Teriparatide Pen Injection in Severely Osteoporotic Patients CATS
Status:
COMPLETED
Status Verified Date:
2007-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purposes of this study are to evaluate the acceptance of the subcutaneous drug teriparatide over 6 months of therapy in patients with severe osteoporosis in Canada and to evaluate how often such patients are actually able to use the injection to obtain additional safety data side effect data that will supplement the existing database of adverse events that have been reported to-date in clinical trials by patients treated with teriparatide to document the prior use of other osteoporosis therapies in this patient population and ongoing use of other osteoporosis therapies during the study and to describe the baseline demographics and disease state of these severely osteoporotic patientsThe purposes of the study extension are to continue to assess the acceptance of the subcutaneous drug teriparatide over up to 18 months of therapy in patients with severe osteoporosis in Canada and to continue to assess how often such patients are actually able to use the injection to obtain additional safety data side effects that will supplement the existing database of adverse events that have been reported to date in clinical trials by patients treated with teriparatide
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| B3D-CA-GHCP | None | None | None |